XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenues (Note 1D) $ 100,000
Expenses:    
Research and development (790,413)
General and administrative (Note 6) (1,773,839) (557,300)
Total operating expenses (2,564,252) (557,300)
Operation Loss (2,464,252) (557,300)
Finance expense:    
Finance expense, net (Note 7) (22,542,234) (307,516)
Net loss from continuing operations available to shareholders of the company (25,006,486) (864,816)
Net loss from discontinued operations available to shareholders of the company) Note 1C) (709,090)
Net loss from continuing operations attributable to shareholders of the company (25,006,486) (1,573,906)
Net loss attributable to shareholders of preferred stock 39,491
Net loss from continuing operations $ (25,006,486) $ (1,534,415)
Basic and diluted net loss per share    
From continuing operations $ (0.41) $ (0.04)
From discontinued operations $ (0.03)
Weighted average shares outstanding - basic and diluted 61,165,674 21,780,899